Dianthus Therapeutics (DNTH) Receivables - Net (2022 - 2025)
Historic Receivables - Net for Dianthus Therapeutics (DNTH) over the last 4 years, with Q3 2025 value amounting to $5.0 million.
- Dianthus Therapeutics' Receivables - Net rose 25971.22% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 25971.22%. This contributed to the annual value of $294000.0 for FY2023, which is 9374.47% down from last year.
- Dianthus Therapeutics' Receivables - Net amounted to $5.0 million in Q3 2025, which was up 25971.22% from $39000.0 recorded in Q2 2025.
- Dianthus Therapeutics' 5-year Receivables - Net high stood at $5.0 million for Q3 2025, and its period low was $39000.0 during Q2 2025.
- Over the past 4 years, Dianthus Therapeutics' median Receivables - Net value was $840000.0 (recorded in 2024), while the average stood at $1.5 million.
- Its Receivables - Net has fluctuated over the past 5 years, first surged by 49913.79% in 2024, then crashed by 9535.71% in 2025.
- Dianthus Therapeutics' Receivables - Net (Quarter) stood at $4.7 million in 2022, then tumbled by 93.74% to $294000.0 in 2023, then soared by 372.79% to $1.4 million in 2024, then skyrocketed by 259.71% to $5.0 million in 2025.
- Its last three reported values are $5.0 million in Q3 2025, $39000.0 for Q2 2025, and $1.0 million during Q1 2025.